Information | zerotoninblog

Studien (nach Erscheinungsdatum sortiert)

Hengartner, M. P. (2022). Evidence-biased antidepressant prescription: overmedicalisation, flawed research, and conflicts of interest. Springer Nature.

Horowitz, M., & Wilcock, M. (2022). Newer generation antidepressants and withdrawal effects: reconsidering the role of antidepressants and helping patients to stop. Drug and Therapeutics Bulletin, 60(1), 7-12.

Brown, M. Lewis, S. (2021). The Patient Voice: Antidepressant Withdrawal, Medically Unexplained Symptoms, and Functional Neurological Disorders. Journal of Critical Psychology, Counselling, and Psychotherapy, 20 (4), 14-20.

Hengartner, M. P., & Plöderl, M. (2021). Prophylactic effects or withdrawal reactions? An analysis of time-to-event data from antidepressant relapse prevention trials submitted to the FDA. Therapeutic Advances in Psychopharmacology, 11, 20451253211032051.

Massabki, I., & Abi-Jaoude, E. (2021). Selective serotonin reuptake inhibitor ‘discontinuation syndrome’or withdrawal. The British Journal of Psychiatry, 218(3), 168-171.

White, E., Read, J., & Julo, S. (2021). The role of Facebook groups in the management and raising of awareness of antidepressant withdrawal: is social media filling the void left by health services?. Therapeutic advances in psychopharmacology, 11, 2045125320981174.

Cosci, F., & Chouinard, G. (2020). Acute and persistent withdrawal syndromes following discontinuation of psychotropic medications. Psychotherapy and Psychosomatics, 1-24.

Fava, G. A. (2020). May antidepressant drugs worsen the conditions they are supposed to treat? The clinical foundations of the oppositional model of tolerance. Therapeutic Advances in Psychopharmacology, 10, 2045125320970325.

Groot, P. C., & van Os, J. (2020). How user knowledge of psychotropic drug withdrawal resulted in the development of person-specific tapering medication. Therapeutic Advances in Psychopharmacology.

Guy, A., Brown, M., Lewis, S., & Horowitz, M. (2020). The ‘patient voice’: patients who experience antidepressant withdrawal symptoms are often dismissed, or misdiagnosed with relapse, or a new medical condition. Therapeutic Advances in Psychopharmacology, 10, 2045125320967183.

Hengartner MP, Schulthess L, Sorensen A, & Framer A. (2020). Protracted withdrawal syndrome after stopping antidepressants: a descriptive quantitative analysis of consumer narratives from a large internet forum. Ther Adv Psychopharmacol, 10, 1-13.

Hengartner, M. P., Davies, J., & Read, J. (2020). Antidepressant withdrawal–the tide is finally turning. Epidemiology and Psychiatric Sciences, 29.

Hengartner, M. P., Jakobsen, J. C., Sørensen, A., & Plöderl, M. (2020). Efficacy of new-generation antidepressants assessed with the Montgomery-Asberg Depression Rating Scale, the gold standard clinician rating scale: A meta-analysis of randomised placebo-controlled trials. PloS one, 15(2), e0229381.

Kulkarni, H., Kulkarni, S., & Saiyad, M. (2020). Severe antidepressant discontinuation syndrome for fluoxetine. Annals of Indian Psychiatry, 4(1), 98.

Davies, J., & Read, J. (2019). A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based?. Addictive behaviors, 97, 111-121.

Davies, J., Read, J., Hengartner, M. P., Cosci, F., Fava, G., Chouinard, G., ... & Offidani, E. (2019). Clinical guidelines on antidepressant withdrawal urgently need updating. Bmj, 365.

Fava, G. A., & Cosci, F. (2019). Understanding and managing withdrawal syndromes after discontinuation of antidepressant drugs. The Journal of clinical psychiatry, 80 (6), 0-0.

Fava, G. A., & Cosci, F. (2019). Addressing clinical challenges of antidepressant discontinuation. American Journal of Psychiatry, 176(6), 487-488.

Horowitz, M. A., & Taylor, D. (2019). Tapering of SSRI treatment to mitigate withdrawal symptoms. The Lancet Psychiatry, 6(6), 538-54.

Iacobucci, G. (2019). NICE updates antidepressant guidelines to reflect severity and length of withdrawal symptoms. BMJ: British Medical Journal (Online), 367.

Récalt, A. M., & Cohen, D. (2019). Withdrawal confounding in randomized controlled trials of antipsychotic, antidepressant, and stimulant drugs, 2000–2017. Psychotherapy and psychosomatics, 88(2), 105-113.

Fava, G. A., Benasi, G., Lucente, M., Offidani, E., Cosci, F., & Guidi, J. (2018). Withdrawal symptoms after serotonin-noradrenaline reuptake inhibitor discontinuation: systematic review. Psychotherapy and Psychosomatics, 87(4), 195-203.

Stockmann, T., Odegbaro, D., Timimi, S., & Moncrieff, J. (2018). SSRI and SNRI withdrawal symptoms reported on an internet forum. International Journal of Risk & Safety in Medicine, 29(3-4), 175-180.

Carvalho, A. F., Sharma, M. S., Brunoni, A. R., Vieta, E., & Fava, G. A. (2016). The safety, tolerability and risks associated with the use of newer generation antidepressant drugs: a critical review of the literature. Psychotherapy and psychosomatics, 85(5), 270-288.

Chouinard, G., & Chouinard, V. A. (2015). New classification of selective serotonin reuptake inhibitor withdrawal. Psychotherapy and Psychosomatics, 84(2), 63-71.

Fava, G. A., Gatti, A., Belaise, C., Guidi, J., & Offidani, E. (2015). Withdrawal symptoms after selective serotonin reuptake inhibitor discontinuation: a systematic review. Psychotherapy and psychosomatics, 84(2), 72-81.

Belaise, C., Gatti, A., Chouinard, V. A., & Chouinard, G. (2012). Patient online report of selective serotonin reuptake inhibitor-induced persistent postwithdrawal anxiety and mood disorders. Psychotherapy and psychosomatics, 81(6), 386-388.

Nielsen, M., Hansen, E. H., & Gøtzsche, P. C. (2012). What is the difference between dependence and withdrawal reactions? A comparison of benzodiazepines and selective serotonin re‐uptake inhibitors. Addiction, 107(5), 900-908.

Moncrieff, J. (2006). Why is it so difficult to stop psychiatric drug treatment?: It may be nothing to do with the original problem. Medical Hypotheses, 67(3), 517-523.

Warner, C. H., Bobo, W., Warner, C. M., Reid, S., & Rachal, J. (2006). Antidepressant discontinuation syndrome. American family physician, 74(3), 449-456.

Studien zu Kindling-Effekten bzw.nervous system destabilization:

Framer, A. (2021). What I have learnt from helping thousands of people taper off antidepressants and other psychotropic medications. Therapeutic Advances in Psychopharmacology, 11, 2045125321991274.

Kraus, J. E. (2000). Sensitization phenomena in psychiatric illness: lessons from the kindling model. The Journal of neuropsychiatry and clinical neurosciences, 12(3), 328-343.

Kaymaz, N., van Os, J., Loonen, A. J., & Nolen, W. A. (2008). Evidence that patients with single versus recurrent depressive episodes are differentially sensitive to treatment discontinuation: a meta-analysis of placebo-controlled randomized trials. The Journal of clinical psychiatry, 69(9), 6813.

Bell, I. R., Rossi 3rd, J., Gilbert, M. E., Kobal, G., Morrow, L. A., Newlin, D. B., ... & Wood, R. W. (1997). Testing the neural sensitization and kindling hypothesis for illness from low levels of environmental chemicals. Environmental Health Perspectives, 105(suppl 2), 539-547.

Onlinequellen, Bücher, Artikel

International Institute for Psychiatric Drug Withdrawal IIPDW
https://iipdw.org/

How hard is it to stop antidepressants? https://www.apa.org/monitor/2020/04/stop-antidepressants

Stockmann, T. (2019). What it was like to stop an antidepressant. Therapeutic advances in psychopharmacology, 9, 2045125319884834.

https://www.madinamerica.com/2021/01/finding-ones-way-withdrawal/

https://www.madinamerica.com/2021/03/antidepressant-withdrawal-misdiagnosed-functional-disorders/

Stopping antidepressants
https://www.rcpsych.ac.uk/mental-health/treatments-and-wellbeing/stopping-antidepressants

Ed White (RIP) https://www.telegraph.co.uk/health-fitness/mind/broke-loose-truth-coming-anti-depressants/